Scourge provides a definitive account of the dramatic story of smallpox by a leading "expert on biological and chemical weapons" (The New York Times). Jonathan B. Tucker traces the history of the smallpox virus from its first recorded outbreak around 3700 b.c. through its use as the first biological warfare agent in human history, and draws some decisively important lessons for the future. In a timely debate, Tucker addresses the ever-growing concerns about the proliferation of the deadly smallpox virus and its use by terrorist organizations. Explaining how the eradication of the disease in the late 1970s encouraged military research and production of the virus, he exposes the failure of the Russian government to secure its remaining coldwar stockpiles, and evaluates the past and present measures undertaken by the United States to counter the existing dangers of a smallpox attack. Ultimately, he passionately argues for the strengthening of the existing legal ban on the development and possession of biological weapons. Impeccably researched, Scourge is as arresting as it is indispensable, and as William Beatty in Booklist raves, Tucker "has a sense of both the detail and the broad sweep of history that helps him make the story of smallpox as disease and as weapon fascinating and frightening."

This contains a case study for the study of weapons of mass destruction. It recounts the important events that led to the ratification of chemical weapons. It uses direct quotes to explain the events that led up to the ratification.

In-depth case studies of twelve terrorist groups and individuals who, from 1946 to 1998, allegedly acquired or employed CBW agents. Policymakers, scholars, and the news media have been alarmed by the potential for chemical and biological weapons (CBW) terrorism, and the U.S. Congress has allocated billions of dollars for counterterrorism and "consequence management" programs. Driving these concerns are the global spread of scientific knowledge and technology relevant to CBW terrorism and the vulnerability of civilian populations to chemical and biological attacks. Notably lacking from the analysis, however, has been a careful assessment of the terrorists themselves. What types of terrorist groups or individuals are both capable of acquiring chemical and biological weapons and motivated to use them, and for what purposes? Further, what types of toxic agents would probably be produced, and how would they be delivered? Answers to these questions would enable policymakers to prepare for the most likely contingencies. To this end, Toxic Terror provides in-depth case studies of twelve terrorist groups and individuals who, from 1946 to 1998, allegedly acquired or employed CBW agents. The cases were researched from primary sources, including court documents, interviews, and declassified government files. By comparing the twelve cases, the book identifies characteristic motivations and patterns of behavior associated with CBW terrorism and provides an empirical basis for prudent, cost-effective strategies of prevention and response.

A framework for assessing the security risks of emerging dual-use technologies and devising tailored governance strategies is proposed and applied to contemporary case studies. Recent advances in disciplines such as biotechnology, nanotechnology, and neuropharmacology entail a "dual-use dilemma" because they promise benefits for human health and welfare yet pose the risk of misuse for hostile purposes. The emerging field of synthetic genomics, for example, can produce custom DNA molecules for life-saving drugs but also makes possible the creation of deadly viral agents for biological warfare or terrorism. The challenge for policymakers is to prevent the misuse of these new technologies without forgoing their benefits. Innovation, Dual Use, and Security offers a systematic approach for managing the dual-use dilemma. The book presents a "decision framework" for assessing the security risks of emerging technologies and fashioning governance strategies to manage those risks. This framework is applied to fourteen contemporary case studies, including synthetic genomics, DNA shuffling and directed evolution, combinatorial chemistry, protein engineering, immunological modulation, and aerosol vaccines. The book also draws useful lessons from two historical cases: the development of the V-series nerve agents in Britain and the use and misuse of LSD by the U.S. Army and the CIA. Innovation, Dual Use, and Security offers a comprehensive, multifaceted introduction to the challenges of governing dual-use technologies in an era of rapid innovation. The book will be of interest to government officials and other practitioners as well as to students and scholars in security studies, science and technology studies, biology, and chemistry.